Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Lan

Showing results (621-630 of 632) with videos related to

Pageof 64
Sort By:
The Lancet. Gastroenterology & Hepatology|October 24, 2021
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trialHuabin Hu, Liang Kang, Jianwei Zhang, et al.
Leukemia|September 15, 2018
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemiaDonia M Moujalled, Giovanna Pomilio, Corina Ghiurau, et al.
Science Immunology|September 22, 2023
Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8<sup>+</sup> T cell metabolic fitness and function in tumorsJie-Feng Yang, Xudong Xing, Li Luo, et al.
Gastroenterology|July 10, 2021
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer ProgressionTuo Hu, Surendra K Shukla, Enza Vernucci, et al.
The Oncologist|February 5, 2021
College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal CancerHai-Yang Chen, Li-Li Feng, Ming Li, et al.
The Lancet. Oncology|July 1, 2026
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trialHuabin Hu, Xutao Shen, Yunfeng Li, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic AgonistsJason M Cox, Hong D Chu, Mariappan V Chelliah, et al.
ACS Chemical Biology|August 31, 2022
A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected CellsKeith P Moore, Adam G Schwaid, Matthew Tudor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2024
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL TrialHuabin Hu, Jianwei Zhang, Yunfeng Li, et al.
Gastroenterology Report|February 28, 2020
International consensus on natural orifice specimen extraction surgery (NOSES) for gastric cancer (2019)Xu Guan, Zheng Liu, Amjad Parvaiz, et al.
Pageof 64

Showing results (621-630 of 632) with videos related to

Sort By:
Pageof 64
The Lancet. Gastroenterology & Hepatology|October 24, 2021
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trialHuabin Hu, Liang Kang, Jianwei Zhang, et al.
Leukemia|September 15, 2018
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemiaDonia M Moujalled, Giovanna Pomilio, Corina Ghiurau, et al.
Science Immunology|September 22, 2023
Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8<sup>+</sup> T cell metabolic fitness and function in tumorsJie-Feng Yang, Xudong Xing, Li Luo, et al.
Gastroenterology|July 10, 2021
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer ProgressionTuo Hu, Surendra K Shukla, Enza Vernucci, et al.
The Oncologist|February 5, 2021
College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal CancerHai-Yang Chen, Li-Li Feng, Ming Li, et al.
The Lancet. Oncology|July 1, 2026
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trialHuabin Hu, Xutao Shen, Yunfeng Li, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic AgonistsJason M Cox, Hong D Chu, Mariappan V Chelliah, et al.
ACS Chemical Biology|August 31, 2022
A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected CellsKeith P Moore, Adam G Schwaid, Matthew Tudor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2024
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL TrialHuabin Hu, Jianwei Zhang, Yunfeng Li, et al.
Gastroenterology Report|February 28, 2020
International consensus on natural orifice specimen extraction surgery (NOSES) for gastric cancer (2019)Xu Guan, Zheng Liu, Amjad Parvaiz, et al.
Pageof 64